Modern Pathology
Издатель: Springer Nature · 7 статей
-
Inside the USCAP Journals
Modern Pathology, Published online: 29 November 2022; doi:10.1038/s41379-022-01171-y Inside the USCAP Journals
-
A tribute to Prof. Ondrej Hes, MD, PhD (1968–2022)
Modern Pathology, Published online: 04 November 2022; doi:10.1038/s41379-022-01159-8 A tribute to Prof. Ondrej Hes, MD, PhD (1968–2022)
-
Correction to: Expression of phosphorylated ribosomal protein S6 in mesothelioma patients - correlation with clinico-pathological characteristics and outcome: results from the European Thoracic Oncology Platform (ETOP) Mesoscape project
Modern Pathology, Published online: 17 October 2022; doi:10.1038/s41379-022-01170-z Correction to: Expression of phosphorylated ribosomal protein S6 in mesothelioma patients - correlation with clinico-pathological characteristics and...
-
Variability in endometrial carcinoma pathology practice: opportunities for improvement with molecular classification
Modern Pathology, Published online: 14 October 2022; doi:10.1038/s41379-022-01165-w Variability in endometrial carcinoma pathology practice: opportunities for improvement with molecular classification
-
Comment on HPV-independent, p53-wild-type vulvar intraepithelial neoplasia: a review of nomenclature and the journey to characterize acanthotic precursor lesions of the vulva. Parra-Herran C. et al Mod Pathol 2022 Apr 18 doi: 10.1038/s41379-022-01079-7
Modern Pathology, Published online: 14 October 2022; doi:10.1038/s41379-022-01168-7 Comment on HPV-independent, p53-wild-type vulvar intraepithelial neoplasia: a review of nomenclature and the journey to characterize acanthotic...
-
Rethinking the role of biomarkers for operable non-small cell lung carcinoma: an effective collaboration with artificial intelligence algorithms
Modern Pathology, Published online: 07 October 2022; doi:10.1038/s41379-022-01167-8 Rethinking the role of biomarkers for operable non-small cell lung carcinoma: an effective collaboration with artificial intelligence algorithms
-
CINSARC signature outperforms gold-standard TNM staging and consensus molecular subtypes for clinical outcome in stage II–III colorectal carcinoma
Modern Pathology, Published online: 06 October 2022; doi:10.1038/s41379-022-01166-9 CINSARC signature outperforms gold-standard TNM staging and consensus molecular subtypes for clinical outcome in stage II–III colorectal carcinoma